Here are five recommendations regarding prevention and screening of colorectal cancer, according to the U.S. Preventive Services Task Force.
1. The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary.
2. The USPSTF recommends against routine screening for colorectal cancer in adults age 76 to 85 years. There may be considerations that support colorectal cancer screening in an individual patient.
3. The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years.
4. The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer.
5. The USPSTF recommends against the routine use of aspirin and nonsteroidal anti-inflammatory drugs to prevent colorectal cancer in individuals at average risk for colorectal cancer.
Read the USPSTF recommendations on CRC screening and prevention.
Read other coverage about colorectal cancer:
- Missouri Surgeon Utilizes Novel Minimally Invasive Treatment for Colorectal Cancer
- Researchers Say Trained Labrador Can Detect Colon Cancer
- Researchers Study Predictors and Rate of Missed Post-Colonoscopy CRC
1. The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary.
2. The USPSTF recommends against routine screening for colorectal cancer in adults age 76 to 85 years. There may be considerations that support colorectal cancer screening in an individual patient.
3. The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years.
4. The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer.
5. The USPSTF recommends against the routine use of aspirin and nonsteroidal anti-inflammatory drugs to prevent colorectal cancer in individuals at average risk for colorectal cancer.
Read the USPSTF recommendations on CRC screening and prevention.
Read other coverage about colorectal cancer:
- Missouri Surgeon Utilizes Novel Minimally Invasive Treatment for Colorectal Cancer
- Researchers Say Trained Labrador Can Detect Colon Cancer
- Researchers Study Predictors and Rate of Missed Post-Colonoscopy CRC